[2-(1-Hydroxypropan-2-yloxy)-2-methoxyethyl] 5-oxo-5-(2-sulfanylethylamino)pentanoate

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: [2-(1-Hydroxypropan-2-yloxy)-2-methoxyethyl] 5-oxo-5-(2-sulfanylethylamino)pentanoate
• 英文别名: [2-(1-hydroxypropan-2-yloxy)-2-methoxyethyl] 5-oxo-5-(2-sulfanylethylamino)pentanoate
• 化学式: C₁₃H₂₅NO₆S
• 分子量: 323.41
• InChiKey: UVCHLWPXYRJVKM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.4
• 重原子数：
  21
• 可旋转键数：
  13
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.85
• 拓扑面积：
  95.1
• 氢给体数：
  3
• 氢受体数：
  7

文献信息

• PROTEIN-POLYMER-DRUG CONJUGATES
  申请人：Mersana Therapeutics, Inc.

  公开号：EP2717916B1

  公开（公告）日：2017-03-08
• [EN] PROTEIN-POLYMER-DRUG CONJUGATES<br/>[FR] CONJUGUÉS PROTÉINE-POLYMÈRE-MÉDICAMENT
  申请人：MERSANA THERAPEUTICS INC

  公开号：WO2014093394A1

  公开（公告）日：2014-06-19

  A drug conjugate is provided herein. The conjugate comprises a protein based recognition-molecule (PBRM) and a polymeric carrier substituted with one or more -LD-D, the protein based recognition-molecule being connected to the polymeric carrier by Lp. Each occurrence of D is independently a therapeutic agent having a molecular weight < 5 kDa. LD and Lp are linkers connecting the therapeutic agent and PBRM to the polymeric carrier respectively. Also disclosed are polymeric scaffolds useful for conjugating with a PBRM to form a polymer- drug-PBRM conjugate described herein, compositions comprising the conjugates, methods of their preparation, and methods of treating various disorders with the conjugates or their compositions.